Showing results (551-560 of 803) with videos related to

Sort By:
Pageof 81
British Journal of Urology|March 1, 1996
The use of RT-PCR for prostate-specific antigen assay to predict potential surgical failures before radical prostatectomy: molecular staging of prostate cancerC A Olsson, G M De Vries, M C Benson, et al.
The Prostate|December 14, 2002
Acute hypoxia increases the aggressive characteristics and survival properties of prostate cancer cellsMohamed A Ghafar, Aristotelis G Anastasiadis, Min-Wei Chen, et al.
Urology|December 27, 2011
Relative efficacy of perioperative gemcitabine and cisplatin versus methotrexate, vinblastine, adriamycin, and cisplatin in the management of locally advanced urothelial carcinoma of the bladderOlga Yeshchina, Gina M Badalato, Matthew S Wosnitzer, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 17, 2014
Metastatic epidural spinal cord compression among elderly patients with advanced prostate cancerBenjamin A Spencer, Jin Joo Shim, Dawn L Hershman, et al.
Magnetic Resonance Imaging|May 1, 1988
Magnetic resonance imaging of bone after radiationP A Remedios, P M Colletti, J K Raval, et al.
The Journal of Urology|November 1, 1993
The titanium intraprostatic stent: the United States experienceS A Kaplan, D C Merrill, W G Mosely, et al.
Clinical Genitourinary Cancer|November 9, 2017
Oncologic Outcomes of Definitive Treatments for Low- and Intermediate-Risk Prostate Cancer After a Period of Active SurveillanceMichael J Whalen, Jamie S Pak, Danny Lascano, et al.
The Neuroradiology Journal|April 1, 2024
A review of histopathologic and radiologic features of non-atherosclerotic pathologies of the extracranial carotid arteriesAnthony S Larson, Girish Bathla, Waleed Brinjikji, et al.
British Journal of Cancer|October 11, 2001
The treatment of advanced renal cell cancer with high-dose oral thalidomideJ Stebbing, C Benson, T Eisen, et al.
Cancer Journal (Sudbury, Mass.)|June 21, 2002
Postprostatectomy salvage radiation therapy for prostate cancer: impact of pathological and biochemical variables and prostate fossa biopsyMarc R Mosbacher, Peter B Schiff, Kathleen M Otoole, et al.
Pageof 81